399 related articles for article (PubMed ID: 25297560)
1. Cardiac NO signalling in the metabolic syndrome.
Pechánová O; Varga ZV; Cebová M; Giricz Z; Pacher P; Ferdinandy P
Br J Pharmacol; 2015 Mar; 172(6):1415-33. PubMed ID: 25297560
[TBL] [Abstract][Full Text] [Related]
2. Soluble guanylyl cyclase activation improves progressive cardiac remodeling and failure after myocardial infarction. Cardioprotection over ACE inhibition.
Fraccarollo D; Galuppo P; Motschenbacher S; Ruetten H; Schäfer A; Bauersachs J
Basic Res Cardiol; 2014 Jul; 109(4):421. PubMed ID: 24907870
[TBL] [Abstract][Full Text] [Related]
3. Soluble guanylyl cyclase (sGC) degradation and impairment of nitric oxide-mediated responses in urethra from obese mice: reversal by the sGC activator BAY 60-2770.
Alexandre EC; Leiria LO; Silva FH; Mendes-Silvério CB; Calmasini FB; Davel AP; Mónica FZ; De Nucci G; Antunes E
J Pharmacol Exp Ther; 2014 Apr; 349(1):2-9. PubMed ID: 24421320
[TBL] [Abstract][Full Text] [Related]
4. Dysfunctional nitric oxide signalling increases risk of myocardial infarction.
Erdmann J; Stark K; Esslinger UB; Rumpf PM; Koesling D; de Wit C; Kaiser FJ; Braunholz D; Medack A; Fischer M; Zimmermann ME; Tennstedt S; Graf E; Eck S; Aherrahrou Z; Nahrstaedt J; Willenborg C; Bruse P; Brænne I; Nöthen MM; Hofmann P; Braund PS; Mergia E; Reinhard W; Burgdorf C; Schreiber S; Balmforth AJ; Hall AS; Bertram L; Steinhagen-Thiessen E; Li SC; März W; Reilly M; Kathiresan S; McPherson R; Walter U; ; Ott J; Samani NJ; Strom TM; Meitinger T; Hengstenberg C; Schunkert H
Nature; 2013 Dec; 504(7480):432-6. PubMed ID: 24213632
[TBL] [Abstract][Full Text] [Related]
5. Redox signalling: from nitric oxide to oxidized lipids.
Shiva S; Moellering D; Ramachandran A; Levonen AL; Landar A; Venkatraman A; Ceaser E; Ulasova E; Crawford JH; Brookes PS; Patel RP; Darley-Usmar VM
Biochem Soc Symp; 2004; (71):107-20. PubMed ID: 15777016
[TBL] [Abstract][Full Text] [Related]
6. ROS and RNS signalling: adaptive redox switches through oxidative/nitrosative protein modifications.
Moldogazieva NT; Mokhosoev IM; Feldman NB; Lutsenko SV
Free Radic Res; 2018 May; 52(5):507-543. PubMed ID: 29589770
[TBL] [Abstract][Full Text] [Related]
7. Nitric oxide and heat shock protein 90 activate soluble guanylate cyclase by driving rapid change in its subunit interactions and heme content.
Ghosh A; Stasch JP; Papapetropoulos A; Stuehr DJ
J Biol Chem; 2014 May; 289(22):15259-71. PubMed ID: 24733395
[TBL] [Abstract][Full Text] [Related]
8. Human soluble guanylate cyclase as a nitric oxide sensor for NO-signalling reveals a novel function of nitrite reductase.
Pan J; Xu Q; Lin YW; Zhong F; Tan X
Chem Commun (Camb); 2013 Aug; 49(67):7454-6. PubMed ID: 23864033
[TBL] [Abstract][Full Text] [Related]
9. Soluble guanylyl cyclase is a target of angiotensin II-induced nitrosative stress in a hypertensive rat model.
Crassous PA; Couloubaly S; Huang C; Zhou Z; Baskaran P; Kim DD; Papapetropoulos A; Fioramonti X; Durán WN; Beuve A
Am J Physiol Heart Circ Physiol; 2012 Sep; 303(5):H597-604. PubMed ID: 22730391
[TBL] [Abstract][Full Text] [Related]
10. The fibrate gemfibrozil is a NO- and haem-independent activator of soluble guanylyl cyclase: in vitro studies.
Sharina IG; Sobolevsky M; Papakyriakou A; Rukoyatkina N; Spyroulias GA; Gambaryan S; Martin E
Br J Pharmacol; 2015 May; 172(9):2316-29. PubMed ID: 25536881
[TBL] [Abstract][Full Text] [Related]
11. Soluble guanylate cyclase: a potential therapeutic target for heart failure.
Gheorghiade M; Marti CN; Sabbah HN; Roessig L; Greene SJ; Böhm M; Burnett JC; Campia U; Cleland JG; Collins SP; Fonarow GC; Levy PD; Metra M; Pitt B; Ponikowski P; Sato N; Voors AA; Stasch JP; Butler J;
Heart Fail Rev; 2013 Mar; 18(2):123-34. PubMed ID: 22622468
[TBL] [Abstract][Full Text] [Related]
12. Heterogeneous expression of NO-activated soluble guanylyl cyclase in mammalian heart: implications for NO- and redox-mediated indirect versus direct regulation of cardiac ion channel function.
Brahmajothi MV; Campbell DL
Channels (Austin); 2007; 1(5):353-65. PubMed ID: 18690042
[TBL] [Abstract][Full Text] [Related]
13. NO and sGC-stimulating NO donors.
Megson IL; Miller MR
Handb Exp Pharmacol; 2009; (191):247-76. PubMed ID: 19089333
[TBL] [Abstract][Full Text] [Related]
14. NO-independent stimulation or activation of soluble guanylyl cyclase during early reperfusion limits infarct size.
Bice JS; Keim Y; Stasch JP; Baxter GF
Cardiovasc Res; 2014 Feb; 101(2):220-8. PubMed ID: 24259501
[TBL] [Abstract][Full Text] [Related]
15. Regulation of the expression of soluble guanylyl cyclase by reactive oxygen species.
Gerassimou C; Kotanidou A; Zhou Z; Simoes DC; Roussos C; Papapetropoulos A
Br J Pharmacol; 2007 Apr; 150(8):1084-91. PubMed ID: 17339839
[TBL] [Abstract][Full Text] [Related]
16. New insights into the role of soluble guanylate cyclase in blood pressure regulation.
Buys E; Sips P
Curr Opin Nephrol Hypertens; 2014 Mar; 23(2):135-42. PubMed ID: 24419369
[TBL] [Abstract][Full Text] [Related]
17. Role of sGC-dependent NO signalling and myocardial infarction risk.
Wobst J; Kessler T; Dang TA; Erdmann J; Schunkert H
J Mol Med (Berl); 2015 Apr; 93(4):383-94. PubMed ID: 25733135
[TBL] [Abstract][Full Text] [Related]
18. Fluorescence dequenching makes haem-free soluble guanylate cyclase detectable in living cells.
Hoffmann LS; Schmidt PM; Keim Y; Hoffmann C; Schmidt HH; Stasch JP
PLoS One; 2011; 6(8):e23596. PubMed ID: 21858179
[TBL] [Abstract][Full Text] [Related]
19. Prolonged therapy with the soluble guanylyl cyclase activator BAY 60-2770 restores the erectile function in obese mice.
Silva FH; Leiria LO; Alexandre EC; Davel AP; Mónica FZ; De Nucci G; Antunes E
J Sex Med; 2014 Nov; 11(11):2661-70. PubMed ID: 25196910
[TBL] [Abstract][Full Text] [Related]
20. NO-independent, haem-dependent soluble guanylate cyclase stimulators.
Stasch JP; Hobbs AJ
Handb Exp Pharmacol; 2009; (191):277-308. PubMed ID: 19089334
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
